Aeglea Biotherapeutics — 1 Year Data from First in Human Study of Pegzilarginase for the Treatment of Arginase 1 Deficiency (ARG1-D)

13 slides

Aeglea Biotherapeutics · Health & Biotech

Download this PDF

Enter your email to download this deck. We’ll also send occasional updates about new decks.

PPT coming soon -

PPT coming soon

Get an email when PowerPoint downloads are available.

About this deck

Explore the presentation slide by slide for its financial analysis, transaction details, and investor communications.

Read moreRead less
Company
Aeglea Biotherapeutics
Industry
Health & Biotech
Slides
13
Company
Aeglea Biotherapeutics
Industry
Health & Biotech
Slides
13